Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

Sho IwakiShigenori KadowakiKazunori HondaYukiya NaritaToshiki MasuishiHiroya TaniguchiMasashi AndoKei MuroMichi SawabeHidenori SuzukiDaisuke NishikawaShintaro BeppuHoshino TeradaToshihiro KishikawaDaisuke KawakitaNobuhiro Hanai

Published in: International journal of clinical oncology (2024)

This study indicates that cetuximab-containing second-line chemotherapy can improve outcomes in R/M HNSCC, even after first-line therapy failure or intolerance.

Keyphrases

locally advanced
squamous cell carcinoma
small cell lung cancer
rectal cancer
type diabetes
advanced non small cell lung cancer
stem cells
metabolic syndrome
cell therapy
weight loss
glycemic control